Royal Bank of Canada’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13K Sell
788
-3,079
-80% -$55.1K ﹤0.01% 6056
2025
Q4
$62K Sell
3,867
-72,867
-95% -$1.08M ﹤0.01% 5445
2025
Q3
$949K Sell
76,734
-22,143
-22% -$260K ﹤0.01% 4038
2025
Q2
$1.14M Buy
98,877
+89,360
+939% +$1.06M ﹤0.01% 3784
2025
Q1
$143K Buy
9,517
+7,347
+339% +$123K ﹤0.01% 4952
2024
Q4
$38K Sell
2,170
-4,085
-65% -$78.8K ﹤0.01% 5822
2024
Q3
$116K Sell
6,255
-53,068
-89% -$1.07M ﹤0.01% 5235
2024
Q2
$1.2M Buy
59,323
+4,829
+9% +$85.4K ﹤0.01% 3293
2024
Q1
$930K Buy
54,494
+169
+0.3% +$2.66K ﹤0.01% 3521
2023
Q4
$960K Buy
54,325
+4,692
+9% +$94.5K ﹤0.01% 3697
2023
Q3
$1.19M Buy
49,633
+1,589
+3% +$39K ﹤0.01% 3294
2023
Q2
$1.12M Sell
48,044
-11,452
-19% -$259K ﹤0.01% 3270
2023
Q1
$1.31M Buy
59,496
+621
+1% +$14.5K ﹤0.01% 3140
2022
Q4
$1.19M Sell
58,875
-246
-0.4% -$4.77K ﹤0.01% 3353
2022
Q3
$798K Buy
59,121
+2,859
+5% +$48.2K ﹤0.01% 3637
2022
Q2
$1.11M Buy
56,262
+18,971
+51% +$504K ﹤0.01% 3399
2022
Q1
$1.18M Buy
37,291
+1,891
+5% +$53K ﹤0.01% 3503
2021
Q4
$789K Buy
35,400
+3,763
+12% +$98.1K ﹤0.01% 4053
2021
Q3
$879K Sell
31,637
-23,360
-42% -$711K ﹤0.01% 3839
2021
Q2
$2.14M Buy
54,997
+16,989
+45% +$609K ﹤0.01% 3002
2021
Q1
$1.09M Sell
38,008
-14,444
-28% -$493K ﹤0.01% 3493
2020
Q4
$1.39M Buy
52,452
+209
+0.4% +$4.27K ﹤0.01% 3234
2020
Q3
$797K Sell
52,243
-203
-0.4% -$4.26K ﹤0.01% 3454
2020
Q2
$1.07M Buy
52,446
+10,831
+26% +$194K ﹤0.01% 3123
2020
Q1
$430K Buy
41,615
+10,019
+32% +$280K ﹤0.01% 3743
2019
Q4
$1.19M Sell
31,596
-19,675
-38% -$884K ﹤0.01% 3305
2019
Q3
$2.39M Sell
51,271
-7,764
-13% -$361K ﹤0.01% 2611
2019
Q2
$3.09M Buy
59,035
+3,013
+5% +$177K ﹤0.01% 2428
2019
Q1
$3.86M Sell
56,022
-57,906
-51% -$3.88M ﹤0.01% 2197
2018
Q4
$6.8M Sell
113,928
-59,921
-34% -$5.17M ﹤0.01% 1763
2018
Q3
$20.2M Buy
173,849
+40,613
+30% +$4.58M 0.01% 1127
2018
Q2
$16.8M Buy
133,236
+28,089
+27% +$3.42M 0.01% 1180
2018
Q1
$11.4M Buy
105,147
+4,612
+5% +$510K 0.01% 1448
2017
Q4
$11M Sell
100,535
-1,756
-2% -$175K ﹤0.01% 1542
2017
Q3
$10.1M Buy
102,291
+23,318
+30% +$2.26M ﹤0.01% 1538
2017
Q2
$8M Sell
78,973
-504,615
-86% -$54.4M ﹤0.01% 1651
2017
Q1
$67.4M Buy
583,588
+30,017
+5% +$3.49M 0.04% 392
2016
Q4
$66.5M Buy
553,571
+63,232
+13% +$7M 0.04% 407
2016
Q3
$55.1M Buy
490,339
+15,262
+3% +$1.76M 0.03% 470
2016
Q2
$58.9M Buy
475,077
+383,153
+417% +$46.3M 0.04% 404
2016
Q1
$10.3M Sell
91,924
-1,592
-2% -$165K 0.01% 1353
2015
Q4
$10.2M Sell
93,516
-1,465
-2% -$168K 0.01% 1415
2015
Q3
$9.48M Sell
94,981
-20,103
-17% -$2.19M 0.01% 1193
2015
Q2
$13.1M Buy
115,084
+4,990
+5% +$605K 0.01% 1071
2015
Q1
$11.5M Sell
110,094
-68,871
-38% -$7.34M 0.01% 1128
2014
Q4
$21.5M Sell
178,965
-1,286
-0.7% -$169K 0.01% 816
2014
Q3
$26.4M Buy
180,251
+1,311
+0.7% +$202K 0.02% 658
2014
Q2
$29.9M Buy
178,940
+25,416
+17% +$4.52M 0.02% 579
2014
Q1
$30.5M Buy
153,524
+10,430
+7% +$1.97M 0.02% 527
2013
Q4
$27.3M Sell
143,094
-30,801
-18% -$5.73M 0.02% 622
2013
Q3
$29.4M Buy
173,895
+37,635
+28% +$5.84M 0.02% 538
2013
Q2
$20.7M Buy
+136,260
New +$19.3M 0.02% 647

Other funds holding CLB

Royal Bank of Canada's CLB Position: Q1 2026 in Review

Royal Bank of Canada reduced its Core Laboratories (CLB) stake by 80% in Q1 2026, selling an estimated $55.1K and leaving 788 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #6056.

Royal Bank of Canada first reported a position in CLB in Q2 2013 and has held it in 52 quarters since. The position peaked at $67.4M in Q1 2017. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.

  • Royal Bank of Canada held 788 shares of Core Laboratories worth $13K as of Q1 2026.
  • Royal Bank of Canada sold 3,079 Core Laboratories shares in Q1 2026, an estimated $55.1K.
  • Core Laboratories made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6056 holding.
  • Royal Bank of Canada first reported a position in Core Laboratories in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's Core Laboratories position peaked at $67.4M in Q1 2017.
  • 190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.